BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33049234)

  • 21. The preferred treatment for stage I seminoma: a survey of Canadian radiation oncologists.
    Alomary I; Samant R; Genest P; Eapen L; Gallant V
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):696-9; discussion 693-5. PubMed ID: 17100156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers to the implementation of surveillance for stage I testicular seminoma.
    Arvold ND; Catalano PJ; Sweeney CJ; Hoffman KE; Nguyen PL; Balboni TA; Fosså SD; Travis LB; Beard CJ
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):383-9. PubMed ID: 22349043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal treatment in the postorchiectomy management of clinical stage I seminoma.
    Agarwal N; Batten J
    Oncology (Williston Park); 2009 Aug; 23(9):764, 767. PubMed ID: 19777761
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment and prognosis of testicular seminoma].
    Tsukamoto T; Fukui I
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):516-21. PubMed ID: 10790992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Evolving Management of Patients With Clinical Stage I Seminoma.
    Matulewicz RS; Oberlin DT; Sheinfeld J; Meeks JJ
    Urology; 2016 Dec; 98():113-119. PubMed ID: 27527410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-stage testis cancer.
    Foster RS
    Curr Treat Options Oncol; 2001 Oct; 2(5):413-9. PubMed ID: 12057104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of stage-I seminoma. Critical review].
    Santini D; Simeoni F; Bianco V; Chiodini S; Speranza I; Pignatelli E; Marchei P
    Minerva Urol Nefrol; 1995 Mar; 47(1):31-8. PubMed ID: 7570258
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy.
    Mistretta FA; Mazzone E; Palumbo C; Knipper S; Tian Z; Nazzani S; Lattouf JB; Musi G; Perrotte P; Montanari E; Shariat SF; Montorsi F; Saad F; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Aug; 17(4):e793-e801. PubMed ID: 31182339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyses of 98 seminoma cases: a review article.
    Güden M; Ulutin C; Göktas S
    Int Urol Nephrol; 2001; 33(3):529-31. PubMed ID: 12230289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
    Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C
    J Urol; 2020 Jul; 204(1):96-103. PubMed ID: 32003612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Trends for Stage I Testicular Seminoma in an Equal-Access Medical System.
    Wingate JT; Etzioni R; Macdonald DM; Brand TC
    Clin Genitourin Cancer; 2016 Oct; 14(5):438-443. PubMed ID: 26794393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.
    Feldman DR
    Oncology (Williston Park); 2010 Jul; 24(8):761-3. PubMed ID: 20718258
    [No Abstract]   [Full Text] [Related]  

  • 37. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of Mexican-American males with seminoma.
    Di Domenico D; Bridges P; Sharifi R; Rubenstein M; Guinan P
    Rev Invest Clin; 1997; 49(2):93-6. PubMed ID: 9294957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of stage I testicular seminoma over a period of 49 years.
    Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
    Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of testicular cancer--16 years' experience from southwest Finland.
    Sundström J; Salminen E; Nurmi M; Toppari J; Pöllänen P; Pelliniemi LJ; Huhtala S; Rajala P; Laato M
    Scand J Urol Nephrol; 2001 Feb; 35(1):21-5. PubMed ID: 11291682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.